These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28120479)

  • 1. Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis.
    Aggarwal A; Gupta R; Negi VS; Rajasekhar L; Misra R; Singh P; Chaturvedi V; Sinha S
    Clin Exp Immunol; 2017 May; 188(2):254-262. PubMed ID: 28120479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
    Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
    Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary sCD25 as a biomarker of lupus nephritis disease activity.
    Gupta R; Yadav A; Misra R; Aggarwal A
    Lupus; 2015 Mar; 24(3):273-9. PubMed ID: 25305215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare.
    Go DJ; Lee JY; Kang MJ; Lee EY; Lee EB; Yi EC; Song YW
    Lupus; 2018 Sep; 27(10):1600-1615. PubMed ID: 29958502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
    Badr AMM; Farag Y; Abdelshafy M; Riad NM
    Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
    Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL): potential biomarkers of active lupus nephritis.
    Phatak S; Chaurasia S; Mishra SK; Gupta R; Agrawal V; Aggarwal A; Misra R
    Clin Exp Immunol; 2017 Mar; 187(3):376-382. PubMed ID: 27804111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of lupus nephritis activity using urinary retinol-binding protein.
    Sesso R; Rettori R; Nishida S; Sato E; Ajzen H; Pereira AB
    Nephrol Dial Transplant; 1994; 9(4):367-71. PubMed ID: 8084448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between urinary adiponectin level and renal involvement in systemic lupus erythematous.
    Loghman M; Haghighi A; Broumand B; Ataipour Y; Tohidi M; Marzbani C; Fakharran M
    Int J Rheum Dis; 2016 Jul; 19(7):678-84. PubMed ID: 24467624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary prostaglandin D synthase as biomarker in lupus nephritis: a longitudinal study.
    Gupta R; Yadav A; Misra R; Aggarwal A
    Clin Exp Rheumatol; 2015; 33(5):694-8. PubMed ID: 26211517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients.
    Gómez-Puerta JA; Ortiz-Reyes B; Urrego T; Vanegas-García AL; Muñoz CH; González LA; Cervera R; Vásquez G
    Lupus; 2018 Apr; 27(4):637-646. PubMed ID: 29073812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Low-Abundance Urinary Biomarkers in Lupus Nephritis Using Electrochemiluminescence Immunoassays.
    Stanley S; Mok CC; Vanarsa K; Habazi D; Li J; Pedroza C; Saxena R; Mohan C
    Arthritis Rheumatol; 2019 May; 71(5):744-755. PubMed ID: 30618193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity.
    Gupta R; Yadav A; Aggarwal A
    Clin Rheumatol; 2016 Nov; 35(11):2707-2714. PubMed ID: 27624649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary osteoprotegerin: a potential biomarker of lupus nephritis disease activity.
    Gupta R; Aggarwal A; Sinha S; Rajasekhar L; Yadav A; Gaur P; Misra R; Negi VS
    Lupus; 2016 Oct; 25(11):1230-6. PubMed ID: 26936893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary mononuclear cell and disease activity of systemic lupus erythematosus.
    Chan RW; Lai FM; Li EK; Tam LS; Chung KY; Chow KM; Li PK; Szeto CC
    Lupus; 2006; 15(5):262-7. PubMed ID: 16761499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
    Turnier JL; Fall N; Thornton S; Witte D; Bennett MR; Appenzeller S; Klein-Gitelman MS; Grom AA; Brunner HI
    Arthritis Res Ther; 2017 Oct; 19(1):242. PubMed ID: 29065913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
    Abujam B; Cheekatla S; Aggarwal A
    Lupus; 2013 May; 22(6):614-23. PubMed ID: 23629827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated urinary IL-36γ in patients with active lupus nephritis and response to treatment.
    Majumder S; Singh P; Chatterjee R; Pattnaik SS; Aggarwal A
    Lupus; 2021 May; 30(6):921-925. PubMed ID: 33593161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary soluble CD163 is a good biomarker for renal disease activity in lupus nephritis.
    Gupta R; Yadav A; Aggarwal A
    Clin Rheumatol; 2021 Mar; 40(3):941-948. PubMed ID: 32809146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.